Filing Fee Exhibit
424B5 EX-FILING FEES 0001829667 333-294722 N/A N/A 0001829667 1 2026-03-21 2026-03-21 0001829667 2026-03-21 2026-03-21 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-3

Regencell Bioscience Holdings Limited

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Ordinary share, par value US$0.00001 per share   (1)   457(r)       $     $ 500,000,000.00   0.0001381   $ 69,050.00
                                           
Total Offering Amounts:   $ 500,000,000.00         69,050.00
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 69,050.00

 

__________________________________________
Offering Note(s)

(1) The proposed maximum aggregate offering price has been estimated solely for purposes of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended, and reflects the maximum offering price of securities registered hereunder. In accordance with the terms of the sales agreement entered into between the Registrant and the Sales Agent (as defined therein) on March 30, 2026 with respect to an at-the-market offering, the Registrant may offer and sell its ordinary shares, having an aggregate offering price of up to $500,000,000, from time to time through the Sales Agent, subject to certain limitations.